Envíos recientes

Mostrando ítems 76-80 de 13892

A randomized study of intermediate as compared with high doses of interferon-alpha for chronic myeloid leukemia: no differences in cytogenetic responses

2003- Penarrubia, M. J.; Odriozola, J.; González, C.; Massagué, I.; Miguel, A.; [et al.]
Frequency and prognostic value of resistance/intolerance to hydroxycarbamide in 890 patients with polycythaemia vera

2016- Álvarez-Larrán, Alberto; Kerguelen, Ana; Hernández-Boluda, Juan Carlos; Pérez Encinas, Manuel Mateo; Ferrer-Marín, Francisca; [et al.]
A prognostic model for survival after salvage treatment with FLAG-Ida +/- gemtuzumab-ozogamicine in adult patients with refractory/relapsed acute myeloid leukaemia

2016- Bergua, Juan; Montesinos, Pau; Martínez-Cuadrón, David; Fernández-Abellán, Pascual; Serrano, Josefina; [et al.]
Clinical characteristics, prognosis and treatment of myelofibrosis patients with severe thrombocytopenia

2018- Hernández-Boluda, Juan Carlos; Correa, Juan-Gonzalo; Álvarez-Larrán, Alberto; Ferrer-Marín, Francisca; Raya, José-María; [et al.]
Therapy-Related Myeloid Neoplasms in Patients With Acute Promyelocytic Leukemia Treated With All-Trans-Retinoic Acid and Anthracycline-Based Chemotherapy

2010- Montesinos, Pau; González, José D.; González, José; Rayón, Chelo; de Lisa, Elena; [et al.]